Download presentation
Presentation is loading. Please wait.
Published byJunior Hoover Modified over 6 years ago
1
2012: Future Impact of Health Care Reform on Laboratory Business
By: Mark S. Birenbaum, Ph.D. Administrator National Independent Laboratory Association (NILA) November 9, 2012 National Independent Laboratory Association, 906 Olive Street, Suite 1200, Saint Louis, Missouri Telephone: , Fax: , Web Site:
2
Healthcare Reform May Be Good If You Live To Tell About It
3
Tax Versus 1.75% Part B Cuts And Permanent Versus Temporary
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Tax $750m = $7.5b 1.75% Part B Cut (Senate) -1.75% -3.50% -5.25% -7.00% -8.75% 3% Growth $7.85b $8.09b $8.33b $8.58b $8.84b $9.10b $9.38b $9.66b $9.95b $10.24b $10.55b $8.19b $8.28b $8.38b $8.48b $8.59b $9.11b $7.95b $8.04b $8.14b $8.24b $8.34b $.14b $.29b $.44b $.6b $.76b $.79b $.82b $.84b $.86b $.89b $530.9m 6.9% Growth $8.97b $9.59b $10.25b $10.96b $11.71b $12.52b $13.37b $14.31b $15.3b $8.81b $9.26b $9.72b $10.21b $10.72b $11.46b $12.25b $13.1b $14b $8.66b $9.09b $9.55b $10.03b $.15b $.31b $.5b $.7b $.93b $.99b $1.06b $1.12b $1.21b $1.3b November 6, 2009
4
Clinical Laboratory Fee Schedule Cut Effective January 1, 2013
5
Increases to Part B CLFS 2011-2015
Cuts to Part B CLFS 2011 -1.75% ACA* 2012 2013 -2.00% (SGR “fix”) Sequestration Total -9.25% 2014 2015 -12.75% Productivity Adjustments -5.7% Estimated -18.45% MedPAC -10% -28.45% Increases to Part B CLFS CPI 2011 +1.1% 2012 +3.6% 2013 +1.7% 2014 +1.5% Est. (CBO) 2015 +9.6% Overall % + 9.6% = % *ACA: Affordable Care Act
6
Impact of Cuts on Medicare Payments
Test Paid at $10 in 2010 17% Cut
8
September 15, 2011 MedPAC Public Meeting
9
Potential Medicare offset options for repealing the SGR System
TABLE A-4 BLE
10
September 27, 2011 Meeting with MedPAC Attending:
NILA Mark Birenbaum, Ph.D. Julie Allen Erin Will Morton ACLA Alan Mertz Roche Diagnostics Kathleen Claessens MedPAC Mark Miller, Ph.D., Executive Director James Mathews, Ph.D., Deputy Director Ariel Winter, MPP, Principal Policy Analyst
12
George Washington University (GWU) Survey Spring-Fall Commissioned by the National Independent Laboratory Association
13
List of Independent Community Labs for the GWU Survey
l Began with the June 14, 2012, CLIA List of Independent Laboratories in all 50 States (approximately 4,000 laboratories). l Excluded: Laboratories affiliated with other practice structures (i.e., physician office laboratories or hospitals) or other laboratories that did not meet the definition of an independent laboratory. Publicly traded national laboratories (e.g., LabCorp, Quest). Hospital laboratories without a separate federal tax ID number (Medicare reimbursement for hospital laboratories is mainly derived from Medicare Part A). Assisted Reproductive Laboratories/In Vitro Fertilization Laboratories. (These laboratories receive little or no Medicare reimbursement). l Subsequently generated a convenience sample of approximately laboratories. l 77 laboratories from 22 states completed the survey.
14
Market Analysis Profit margin Impact of Medicare cuts Payer mix
Beneficiary mix Case studies Most pressing business concerns
15
Services by Customer Type
Practice Hospitals NH/SNFs ALFs Home CHCs
16
Average Profit Margin 0-3% 4-6% 7-9% 10-12% 12-15% >15%
17
Key Findings: Profit Margin
Laboratories with low profit margins were more likely to: Serve rural communities: Nearly 40 percent of laboratories serving rural communities had low profit margins. Provide most of their stat and same-day turnaround testing to nursing homes/SNFs: 71 percent of labs that provide the majority of their stat and same-day turnaround testing to nursing homes and SNFs had low profit margins.
18
Anticipated Business Challenges
Medicare cuts Nat’l Insurers HIT Regs ACO Medicaid cuts Medicare changes Other Mergers Contract
19
2013 Regulatory Activity Affecting Laboratory Business
Direct access to lab test results – waiting on release of a final rule Molecular test placement and payment – November 2012 CMS decision to place tests on Part B CLFS instead of PFS Laboratory developed tests – regulatory authority to be FDA or CLIA? Health reform – future of state exchanges (laboratory services a required benefit to be provided through the exchange); development of ACOs and other payment reform models
20
NILA’s 2013 Legislative and Regulatory Activity
Meet with MedPAC to Present Results of GWU Survey Partner with Other Lab Associations Through Clinical Laboratory Coalition (CLC) Encourage Members of Congress and Hill Staffers to Visit NILA Members’ Laboratories Take Message to Capitol Hill During “Lame Duck” Session
21
NILA Capitol Hill Day November 14-15, 2012 Liaison Hotel l Washington, DC
22
In 2013 Watch Out For NILA ALERT!!! More Part B CLFS Cuts
Resurrection of Competitive Bidding Proposals Resurrection of Copay/Coinsurance Proposals
23
Challenges Ahead Migration of Independent Physician Practices to Hospitals Restrictive Policies of National Insurance Companies Costs and Difficulties of Adopting and Connecting to Electronic Health Information Systems Decreases in Lab Testing Volumes Due To Poor Economy Changes in Ordering Patterns Frequency Limitations
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.